Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Deprescribing and Patient Education Tools in Hemodialysis Units to Decrease Polypharmacy

NCT03733262 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03733262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03733262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Deprescribing and Patient Education Tools in Hemodialysis Units to Decrease Polypharmacy
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2022
Completion date
March 30, 2026
Enrollment
480 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease on dialysis (diagnosis)